BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36777747)

  • 1. Tolerability of Bowel Preparation and Colonoscopy in IBD Patients: Results From a Prospective, Single-Center, Case-Control Study.
    Bezzio C; Schettino M; Manes G; Andreozzi P; Arena I; Della Corte C; Costetti M; Devani M; Omazzi BF; Saibeni S
    Crohns Colitis 360; 2020 Oct; 2(4):otaa077. PubMed ID: 36777747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.
    Kumar A; Shenoy V; Buckley MC; Durbin L; Mackey J; Mone A; Swaminath A
    Dig Dis Sci; 2022 Oct; 67(10):4851-4865. PubMed ID: 35624326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?
    Mohsen W; Williams AJ; Wark G; Sechi A; Koo JH; Xuan W; Bassan M; Ng W; Connor S
    World J Gastroenterol; 2021 Mar; 27(11):1090-1100. PubMed ID: 33776375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of high and low-volume bowel preparation compared: A real-life single-blinded large-population study.
    Occhipinti V; Soriani P; Bagolini F; Milani V; Rondonotti E; Annunziata ML; Cavallaro F; Vavassori S; Vecchi M; Pastorelli L; Tontini GE
    World J Gastrointest Endosc; 2021 Dec; 13(12):659-672. PubMed ID: 35070027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls.
    Bacsur P; Rutka M; Asbóth A; Resál T; Szántó K; Jójárt B; Bálint A; Ari E; Ajibola W; Kintses B; Fehér T; Pigniczki D; Bor R; Fábián A; Maléth J; Szepes Z; Farkas K; Molnár T
    Therap Adv Gastroenterol; 2023; 16():17562848231174298. PubMed ID: 37324319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic characteristics of patients with inflammatory bowel disease undergoing colonoscopy.
    Thukkani N; Williams JL; Sonnenberg A
    Inflamm Bowel Dis; 2011 Jun; 17(6):1333-7. PubMed ID: 21560196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemic.
    Pinto S; Loddo E; Paba S; Favale A; Chicco F; Onali S; Usai P; Fantini MC
    J Patient Rep Outcomes; 2021 Jun; 5(1):48. PubMed ID: 34165646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis.
    Kim ES; Kim KO; Jang BI; Kim EY; Lee YJ; Lee HS; Jeon SW; Kim HJ; Kim SK;
    Dig Dis Sci; 2017 Sep; 62(9):2489-2497. PubMed ID: 28639128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Toronto IBD Global Endoscopic Reporting [TIGER] Score: A Single, Easy to Use Endoscopic Score for Both Crohn's Disease and Ulcerative Colitis Patients.
    Zittan E; Steinhart AH; Aran H; Milgrom R; Gralnek IM; Zelber-Sagi S; Silverberg MS
    J Crohns Colitis; 2022 May; 16(4):544-553. PubMed ID: 34272937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic ultrasound of the colon for the differentiation of Crohn's disease and ulcerative colitis in comparison with healthy controls.
    Ellrichmann M; Wietzke-Braun P; Dhar S; Nikolaus S; Arlt A; Bethge J; Kuehbacher T; Wintermeyer L; Balschun K; Klapper W; Schreiber S; Fritscher-Ravens A
    Aliment Pharmacol Ther; 2014 Apr; 39(8):823-33. PubMed ID: 24612000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of low-volume split-dose versus same-day morning polyethylene glycol regimen for adequacy of bowel preparation in patients undergoing colonoscopy: A single-blinded randomized controlled trial.
    Anudeep KV; Mohan P; Selvan KS; Chellan D; Hamide A
    Indian J Gastroenterol; 2022 Jun; 41(3):247-257. PubMed ID: 35841521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a split-dose bowel preparation with 2 liters of polyethylene glycol plus ascorbic acid and 1 liter of polyethylene glycol plus ascorbic acid and bisacodyl before colonoscopy.
    Kang SH; Jeen YT; Lee JH; Yoo IK; Lee JM; Kim SH; Choi HS; Kim ES; Keum B; Lee HS; Chun HJ; Kim CD
    Gastrointest Endosc; 2017 Aug; 86(2):343-348. PubMed ID: 27889546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].
    Martín de Carpi J; Vila V; Varea V
    An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
    Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease in a colorectal cancer screening population: Diagnosis and follow-up.
    Bezzio C; Manes G; Schettino M; Arena I; de Nucci G; Della Corte C; Devani M; Mandelli E; Morganti D; Omazzi B; Pellegrini L; Picascia D; Redaelli D; Reati R; Saibeni S
    Dig Liver Dis; 2021 May; 53(5):587-591. PubMed ID: 32863160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Split-dose vs same-day reduced-volume polyethylene glycol electrolyte lavage solution for morning colonoscopy.
    Chan WK; Azmi N; Mahadeva S; Goh KL
    World J Gastroenterol; 2014 Oct; 20(39):14488-94. PubMed ID: 25339836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.